1. 295 Accumulation of 53BP1 in circulating tumor cells during treatment with eribulin identifies chemotherapy-responsive metastatic breast cancer patients. (4th December 2020) Authors: Schochter, Fabienne; Werner, Kim; Köstler, Cäcilia; Müller, Volkmar; Neubauer, Hans; Fehm, Tanja; Friedl, Thomas WP; Polzer, Bernhard; Janni, Wolfgang; Wiesmüller, Lisa Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA). Issue 4 (April 2019) Authors: Bischoff, Joachim; Barinoff, Jana; Mundhenke, Christoph; Bauerschlag, Dirk O.; Costa, Serban-Dan; Herr, Daniel; Lübbe, Kristina; Marmé, Frederik; Maass, Nicolai; von Minckwitz, Gunter; Grischke, Eva-Maria; Müller, Volkmar; Schmidt, Marcus; Gerber, Bernd; Kümmel, Sherko; Schumacher, Claudia; Krabi... Journal: Anti-cancer drugs Issue: Volume 30:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A shift from membranous and stromal syndecan‐1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer. Issue 12 (23rd September 2019) Authors: Kind, Simon; Jaretzke, Annika; Büscheck, Franziska; Möller, Katharina; Dum, David; Höflmayer, Doris; Hinsch, Andrea; Weidemann, Sören; Fraune, Christoph; Möller‐Koop, Christina; Hube‐Magg, Claudia; Simon, Ronald; Wilczak, Waldemar; Lebok, Patrick; Witzel, Isabell; Müller, Volkmar; Schmalfeldt, Ba... Journal: Molecular carcinogenesis Issue: Volume 58:Issue 12(2019) Page Start: 2306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells. (6th January 2020) Authors: Gorges, Tobias M; Kuske, Andra; Röck, Katharina; Mauermann, Oliver; Müller, Volkmar; Peine, Sven; Verpoort, Karl; Novosadova, Vendula; Kubista, Mikael; Riethdorf, Sabine; Pantel, Klaus Journal: Clinical chemistry Issue: Volume 62:Number 11(2016) Page Start: 1504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer. Issue 12 (12th October 2021) Authors: Elazezy, Maha; Prieske, Katharina; Kluwe, Lan; Oliveira‐Ferrer, Leticia; Peine, Sven; Müller, Volkmar; Woelber, Linn; Schmalfeldt, Barbara; Pantel, Klaus; Joosse, Simon A. Journal: Molecular oncology Issue: Volume 15:Issue 12(2021) Page Start: 3615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Breast cancer brain metastases: biology and new clinical perspectives. Issue 1 (December 2016) Authors: Witzel, Isabell; Oliveira-Ferrer, Leticia; Pantel, Klaus; Müller, Volkmar; Wikman, Harriet Journal: Breast cancer research Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characterizing death acceptance among patients with cancer. Issue 4 (10th March 2019) Authors: Philipp, Rebecca; Mehnert, Anja; Lo, Chris; Müller, Volkmar; Reck, Martin; Vehling, Sigrun Journal: Psycho-oncology Issue: Volume 28:Issue 4(2019) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials. (July 2021) Authors: Furlanetto, Jenny; Marmé, Frederik; Seiler, Sabine; Thode, Christian; Untch, Michael; Schmatloch, Sabine; Schneeweiss, Andreas; Bassy, Martina; Fasching, Peter A.; Strik, Dominika; Stickeler, Elmar; Schem, Christian; Karn, Thomas; Grischke, Eva-Maria; Denkert, Carsten; van Mackelenbergh, Marion; ... Journal: European journal of cancer Issue: Volume 152(2021) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Circulating Cellular Communication Network Factor 1 Protein as a Sensitive Liquid Biopsy Marker for Early Detection of Breast Cancer. (30th August 2021) Authors: Bartkowiak, Kai; Heidrich, Isabel; Kwiatkowski, Marcel; Banys-Paluchowski, Maggie; Andreas, Antje; Wurlitzer, Marcus; Geffken, Maria; Voß, Hannah; Zeller, Tanja; Blankenberg, Stefan; Peine, Sven; Joosse, Simon A; Müller, Volkmar; Schlüter, Hartmut; Oliveira-Ferrer, Leticia; Pantel, Klaus Journal: Clinical chemistry Issue: Volume 68:Number 2(2022) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CLRM-14. OPEN-LABEL, MULTINATIONAL, MULTICENTER, PHASE 3B/4 STUDY OF TRASTUZUMAB DERUXTECAN (T-DXD) IN PATIENTS WITH OR WITHOUT BASELINE BRAIN METASTASIS (BM) WITH PREVIOUSLY TREATED ADVANCED/METASTATIC HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–POSITIVE BREAST CANCER (HER2+ BC): DESTINY-BREAST12. (21st September 2021) Authors: Lin, Nancy U; Ciruelos, Eva; Jerusalem, Guy; Müller, Volkmar; Niikura, Naoki; Viale, Giuseppe; Oscroft, Emma; Anand, Shawn; Walker, Graham; Harbeck, Nadia Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗